Dr. Ali Syed

Dr. Ali Syed
Dr. Syed completed his Bachelor’s of Science in Biochemistry at McGil University in 2010, graduating with distinction. He went on to obtain his medical degree from the State University of New York graduating in 2014 Magna Cum Laude and was named to the Alpha Omega Alpha medical honor society. He completed his surgery and urology residency in 2020 at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. His expertise include minimally invasive robotic surgery for urologic cancers, prosthetics for male incontinence and erectile dysfunction, sacral neuromodulation for overactive bladder, lithotripsy for kidney stones, and various BPH procedures including laser prostatectomy, robotic prostatectomy, urolift, and aquablation. Dr. Syed is in the forefront of advancing technology in Urology. He is one of the first Urologists in Western Florida to perform aquablation. He believes aquablation therapy provides dramatic improvement in BPH symptoms by combining real time imaging with robotic execution for patients suffering from BPH. Dr. Syed believes in conservative therapy as first line, only using surgical therapy as last resort. Dr. Syed looks forward in developing a strong doctor-patient relationship with collaborative decision making with his patients.

Languages Spoken:

English, Hindi, Urdu

Medical School:

State University of New York - Upstate Medical University (Magna Cum Laude)


Thomas Jefferson University Hospital


McGill University

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only